THU332 Composite Glucose And Albumin Biomarker Tool Provides Strong Mortality Risk Assessment At Presentation And Throughout Index COVID-19 Hospitalization

Disclosure: N. Torres Rivera: None. K. Baez Rodriguez: None. J. Rebernigg: None. B. Contreras: None. S. Yenari: None. K. Hamad: None. W. Wiese-Rometsch: None. V. Farhangi: None. R. Smith: None. Mounting evidence demonstrates tempo of SARS-CoV-2 clearance and spike protein neutralization is adversely...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres Rivera, Nicole, Baez Rodriguez, Karla, Rebernigg, Janevi, Contreras, Berkis, Yenari, Sage, Hamad, Karen, Wiese-Rometsch, Wilhelmine, Farhangi, Vida, Smith, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553657/
http://dx.doi.org/10.1210/jendso/bvad114.766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553657/
http://dx.doi.org/10.1210/jendso/bvad114.766

Ejemplares similares